ProQR Therapeutics N.V.
PRQR
Cena:
$ 1.56
+0.12 (8.33%)
Valuace
70
Růst
45
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
PROQR ANNOUNCES PLANNED CHANGES TO BOARD COMPOSITION
09-02-2026
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., FEB. 09, 2026 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V....
Více zde
PROQR ANNOUNCES ENCOURAGING AX-0810 PHASE 1 SAFETY AND PK DATA, DEVELOPMENT CANDIDATE SELECTIONS, AND 2026 OUTLOOK
08-01-2026
INITIAL AX-0810 DATA SHOW NO SAFETY SIGNALS AFTER 4 WEEKS OF DOSING AND PHARMACOKINETICS CONSISTENT ...
Více zde
PROQR TO PARTICIPATE IN 8TH ANNUAL EVERCORE HEALTHCARE CONFERENCE
01-12-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., DEC. 01, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. (N...
Více zde
PROQR ANNOUNCES THIRD QUARTER 2025 OPERATING AND FINANCIAL RESULTS
06-11-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., NOV. 06, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. ...
Více zde
PROQR RECEIVES CTA AUTHORIZATION FOR AX-0810 AND ANNOUNCES VIRTUAL INVESTOR AND ANALYST EVENT ON NOVEMBER 3, 2025
20-10-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., OCT. 20, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. (N...
Více zde
PROQR TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN OCTOBER 2025
13-10-2025
LEIDEN, NETHERLANDS AND CAMBRIDGE, MASS. , OCT. 13, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N. V...
Více zde
PROQR ANNOUNCES SECOND QUARTER 2025 OPERATING AND FINANCIAL RESULTS
07-08-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., AUG. 07, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. ...
Více zde
PROQR ANNOUNCES UPCOMING PRESENTATION AT RNA EDITING SUMMIT
28-07-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., JULY 28, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NAS...
Více zde
PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCP
26-06-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., JUNE 26, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NAS...
Více zde
PROQR ANNOUNCES UPCOMING SCIENTIFIC PRESENTATIONS AT ASGCT AND TIDES CONFERENCES
12-05-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MAY 12, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NASD...
Více zde
PROQR ANNOUNCES FIRST QUARTER 2025 OPERATING AND FINANCIAL RESULTS
08-05-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MAY 08, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. (NA...
Více zde
PROQR ANNOUNCES WEBCAST OF PRESENTATION AT THE 2025 CITIZENS LIFE SCIENCES CONFERENCE
02-05-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MAY 02, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (NAS...
Více zde
PROQR ANNOUNCES ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD JUNE 3, 2025
01-05-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MAY 01, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V....
Více zde
PROQR STRENGTHENS LEADERSHIP WITH APPOINTMENTS OF CFO AND CMO TO SUPPORT NEXT PHASE OF GROWTH
14-04-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., APRIL 14, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV....
Více zde
PROQR ANNOUNCES YEAR END 2024 OPERATING AND FINANCIAL RESULTS
13-03-2025
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MARCH 13, 2025 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (N...
Více zde
PROQR APPOINTS PETER A. BEAL, PHD, AS CHIEF ADAR SCIENTIST
10-12-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., DEC. 10, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (NA...
Více zde
PROQR ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT
25-10-2024
LEIDEN, THE NETHERLANDS AND CAMBRIDGE, MASS., OCT. 25, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N...
Více zde
PROQR PRICES $75 MILLION UNDERWRITTEN PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT
22-10-2024
LEIDEN, NETHERLANDS AND CAMBRIDGE, MASS., OCT. 22, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. ...
Více zde
PROQR ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF ORDINARY SHARES
22-10-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., OCT. 22, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. (...
Více zde
PROQR HIGHLIGHTS UPCOMING PRESENTATION AT 20TH ANNUAL MEETING OF THE OLIGONUCLEOTIDE THERAPEUTICS SOCIETY
07-10-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., OCT. 07, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NAS...
Více zde
PROQR ANNOUNCES WEBCAST PRESENTATION AT THE 2024 CANTOR GLOBAL HEALTHCARE CONFERENCE
10-09-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., SEPT. 10, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (N...
Více zde
PROQR ANNOUNCES FIRST QUARTER 2024 OPERATING AND FINANCIAL RESULTS
09-05-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MAY 09, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (N...
Více zde
PROQR NOMINATES MARTIN MAIER, PHD TO BOARD AND ANNOUNCES ANNUAL MEETING OF SHAREHOLDERS TO BE HELD MAY 22, 2024
23-04-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., APRIL 23, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (N...
Více zde
PROQR HIGHLIGHTS UPCOMING PRESENTATIONS ON AXIOMER™ RNA EDITING AT ASGCT 27TH ANNUAL MEETING
22-04-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., APRIL 22, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NA...
Více zde
PROQR ACHIEVES SUCCESSFUL DEFENSE OF NEW CHALLENGE TO ITS AXIOMER™ IP PORTFOLIO
19-04-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., APRIL 19, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS N.V. (...
Více zde
PROQR ANNOUNCES YEAR END 2023 OPERATING AND FINANCIAL RESULTS
13-03-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., MARCH 13, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (N...
Více zde
PROQR HIGHLIGHTS NEW PLATFORM DATA FROM PRESENTATION ON AXIOMER™ RNA EDITING TECHNOLOGY AT DEAMINET 2024
19-01-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., JAN. 19, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NAS...
Více zde
PROQR AND RETT SYNDROME RESEARCH TRUST JOIN FORCES WITH AXIOMER™ RNA EDITING COLLABORATION
05-01-2024
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., JAN. 05, 2024 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV (NAS...
Více zde
PROQR THERAPEUTICS ANNOUNCES TRANSACTION COMPLETED FOR THÉA TO ACQUIRE SEPOFARSEN AND ULTEVURSEN OPHTHALMIC ASSETS
08-12-2023
DIVESTMENT OF SEPOFARSEN AND ULTEVURSEN COMPLETED – THÉA TO CONTINUE DEVELOPMENT OF SEPOFARSEN AN...
Více zde
PROQR ANNOUNCES THIRD QUARTER 2023 OPERATING AND FINANCIAL RESULTS
07-11-2023
LEIDEN, NETHERLANDS & CAMBRIDGE, MASS., NOV. 07, 2023 (GLOBE NEWSWIRE) -- PROQR THERAPEUTICS NV. (...
Více zde
Dokumenty nejsou k dispozici
